Header Logo

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Che-Ping Cheng and Heng-Jie Cheng.
Connection Strength

1.677
  1. Cheng HJ, Grant KA, Han QH, Daunais JB, Friedman DP, Masutani S, Little WC, Cheng CP. Up-regulation and functional effect of cardiac ß3-adrenoreceptors in alcoholic monkeys. Alcohol Clin Exp Res. 2010 Jul; 34(7):1171-81.
    View in: PubMed
    Score: 0.453
  2. Li T, Cheng HJ, Ohte N, Hasegawa H, Morimoto A, Herrington DM, Little WC, Li W, Cheng CP. C-Type Natriuretic Peptide Improves Left Ventricular Functional Performance at Rest and Restores Normal Exercise Responses after Heart Failure. J Pharmacol Exp Ther. 2016 06; 357(3):545-53.
    View in: PubMed
    Score: 0.170
  3. Zhou P, Cheng CP, Li T, Ferrario CM, Cheng HJ. Modulation of cardiac L-type Ca2+ current by angiotensin-(1-7): normal versus heart failure. Ther Adv Cardiovasc Dis. 2015 Dec; 9(6):342-53.
    View in: PubMed
    Score: 0.161
  4. Masutani S, Cheng HJ, Morimoto A, Hasegawa H, Han QH, Little WC, Cheng CP. ß3-Adrenergic receptor antagonist improves exercise performance in pacing-induced heart failure. . 2013 Sep 15; 305(6):H923-30.
    View in: PubMed
    Score: 0.141
  5. Masutani S, Cheng HJ, Tachibana H, Little WC, Cheng CP. Levosimendan restores the positive force-frequency relation in heart failure. . 2011 Aug; 301(2):H488-96.
    View in: PubMed
    Score: 0.121
  6. Masutani S, Little WC, Hasegawa H, Cheng HJ, Cheng CP. Restrictive left ventricular filling pattern does not result from increased left atrial pressure alone. Circulation. 2008 Mar 25; 117(12):1550-4.
    View in: PubMed
    Score: 0.097
  7. Masutani S, Cheng HJ, Hyttilä-Hopponen M, Levijoki J, Heikkilä A, Vuorela A, Little WC, Cheng CP. Orally available levosimendan dose-related positive inotropic and lusitropic effect in conscious chronically instrumented normal and heart failure dogs. J Pharmacol Exp Ther. 2008 Apr; 325(1):236-47.
    View in: PubMed
    Score: 0.096
  8. Cheng CP, Cheng HJ, Cunningham C, Shihabi ZK, Sane DC, Wannenburg T, Little WC. Angiotensin II type 1 receptor blockade prevents alcoholic cardiomyopathy. Circulation. 2006 Jul 18; 114(3):226-36.
    View in: PubMed
    Score: 0.087
  9. Zhang ZS, Cheng HJ, Onishi K, Ohte N, Wannenburg T, Cheng CP. Enhanced inhibition of L-type Ca2+ current by beta3-adrenergic stimulation in failing rat heart. J Pharmacol Exp Ther. 2005 Dec; 315(3):1203-11.
    View in: PubMed
    Score: 0.082
  10. Tachibana H, Cheng HJ, Ukai T, Igawa A, Zhang ZS, Little WC, Cheng CP. Levosimendan improves LV systolic and diastolic performance at rest and during exercise after heart failure. . 2005 Feb; 288(2):H914-22.
    View in: PubMed
    Score: 0.077
  11. Morimoto A, Hasegawa H, Cheng HJ, Little WC, Cheng CP. Endogenous beta3-adrenoreceptor activation contributes to left ventricular and cardiomyocyte dysfunction in heart failure. . 2004 Jun; 286(6):H2425-33.
    View in: PubMed
    Score: 0.073
  12. Hasegawa H, Little WC, Ohno M, Brucks S, Morimoto A, Cheng HJ, Cheng CP. Diastolic mitral annular velocity during the development of heart failure. J Am Coll Cardiol. 2003 May 07; 41(9):1590-7.
    View in: PubMed
    Score: 0.070
  13. Li T, Zhang X, Cheng HJ, Zhang Z, Ahmad S, Varagic J, Li W, Cheng CP, Ferrario CM. Critical role of the chymase/angiotensin-(1-12) axis in modulating cardiomyocyte contractility. Int J Cardiol. 2018 08 01; 264:137-144.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.